1. Home
  2. CLGN vs XHLD Comparison

CLGN vs XHLD Comparison

Compare CLGN & XHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • XHLD
  • Stock Information
  • Founded
  • CLGN 2004
  • XHLD 2011
  • Country
  • CLGN Israel
  • XHLD United States
  • Employees
  • CLGN N/A
  • XHLD N/A
  • Industry
  • CLGN Industrial Specialties
  • XHLD
  • Sector
  • CLGN Health Care
  • XHLD
  • Exchange
  • CLGN Nasdaq
  • XHLD NYSE
  • Market Cap
  • CLGN 19.1M
  • XHLD 17.6M
  • IPO Year
  • CLGN N/A
  • XHLD 2025
  • Fundamental
  • Price
  • CLGN $2.31
  • XHLD $0.40
  • Analyst Decision
  • CLGN Strong Buy
  • XHLD Strong Buy
  • Analyst Count
  • CLGN 2
  • XHLD 1
  • Target Price
  • CLGN $11.50
  • XHLD $8.00
  • AVG Volume (30 Days)
  • CLGN 69.8K
  • XHLD 517.5K
  • Earning Date
  • CLGN 08-19-2025
  • XHLD 08-20-2025
  • Dividend Yield
  • CLGN N/A
  • XHLD N/A
  • EPS Growth
  • CLGN N/A
  • XHLD N/A
  • EPS
  • CLGN N/A
  • XHLD N/A
  • Revenue
  • CLGN $2,472,000.00
  • XHLD $3,115,000.00
  • Revenue This Year
  • CLGN $1,999.42
  • XHLD $42.64
  • Revenue Next Year
  • CLGN $69.81
  • XHLD $65.31
  • P/E Ratio
  • CLGN N/A
  • XHLD N/A
  • Revenue Growth
  • CLGN N/A
  • XHLD N/A
  • 52 Week Low
  • CLGN $1.31
  • XHLD $0.33
  • 52 Week High
  • CLGN $5.45
  • XHLD $8.54
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 65.19
  • XHLD N/A
  • Support Level
  • CLGN $2.16
  • XHLD N/A
  • Resistance Level
  • CLGN $2.28
  • XHLD N/A
  • Average True Range (ATR)
  • CLGN 0.18
  • XHLD 0.00
  • MACD
  • CLGN 0.11
  • XHLD 0.00
  • Stochastic Oscillator
  • CLGN 86.24
  • XHLD 0.00

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About XHLD TEN HOLDINGS INC

TEN Holdings Inc is a provider of event planning, production, and broadcasting services. The company produces virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by its Xyvid Pro Platform. Physical events involve live streaming and video recording of physical events. The Company operates business as one operating segment which includes two revenue types: Hybrid and Virtual Events and Physical Events.

Share on Social Networks: